Jason H. Bielas, Ph.D.
Affiliations: | 2003 | York University, Toronto, Ontario, Canada |
Area:
Genetics, Cell BiologyGoogle:
"Jason Bielas"Parents
Sign in to add mentorJohn A. Heddle | grad student | 2003 | York University | |
(The role of proliferation in mutagenesis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rose JC, Stephany JJ, Valente WJ, et al. (2017) Rapidly inducible Cas9 and DSB-ddPCR to probe editing kinetics. Nature Methods |
Valente WJ, Ericson NG, Long AS, et al. (2016) Mitochondrial DNA exhibits resistance to induced point and deletion mutations. Nucleic Acids Research |
Gregory MT, Bertout JA, Ericson NG, et al. (2015) Targeted single molecule mutation detection with massively parallel sequencing. Nucleic Acids Research |
Wanagat J, Ahmadieh N, Bielas JH, et al. (2015) Skeletal muscle mitochondrial DNA deletions are not increased in CuZn-superoxide dismutase deficient mice. Experimental Gerontology. 61: 15-9 |
Ericson NG, Kulawiec M, Vermulst M, et al. (2012) Decreased mitochondrial DNA mutagenesis in human colorectal cancer. Plos Genetics. 8: e1002689 |
Allen JM, Simcha DM, Ericson NG, et al. (2011) Roles of DNA polymerase I in leading and lagging-strand replication defined by a high-resolution mutation footprint of ColE1 plasmid replication. Nucleic Acids Research. 39: 7020-33 |
Wright JH, Modjeski KL, Bielas JH, et al. (2011) A random mutation capture assay to detect genomic point mutations in mouse tissue Nucleic Acids Research. 39: e73 |
Kulawiec M, Salk JJ, Ericson NG, et al. (2010) Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer. Environmental and Molecular Mutagenesis. 51: 427-39 |
Vermulst M, Bielas JH, Loeb LA. (2008) Quantification of random mutations in the mitochondrial genome Methods. 46: 263-268 |
Loeb LA, Bielas JH, Beckman RA. (2008) Cancers exhibit a mutator phenotype: Clinical implications Cancer Research. 68: 3551-3557 |